Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

TLSI TriSalus Life Sciences Inc

4,86

-0,07 (-1,42%)

21 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

TriSalus Life Sciences (NASDAQ:TLSI)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more TriSalus Life Sciences Charts.

TriSalus Life Sciences (NASDAQ:TLSI)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more TriSalus Life Sciences Charts.

News TriSalus Life Sciences Inc

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 10 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

TriSalus Reports Q3 2024 Financial Results and Provides Business Update
Donnerstag 14 November 2024 (2 Monate vor) • Business Wire

TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
Montag 11 November 2024 (2 Monate vor) • Business Wire

TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment
Donnerstag 7 November 2024 (2 Monate vor) • Business Wire

TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
Donnerstag 31 Oktober 2024 (3 Monate vor) • Business Wire

TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
Montag 14 Oktober 2024 (3 Monate vor) • Business Wire

TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board
Donnerstag 26 September 2024 (4 Monate vor) • Business Wire

TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System
Montag 23 September 2024 (4 Monate vor) • Business Wire

TriSalus Reports Q2 2024 Financial Results and Business Update
Donnerstag 15 August 2024 (5 Monate vor) • Business Wire

TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
Donnerstag 1 August 2024 (6 Monate vor) • Business Wire

TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation
Montag 1 Juli 2024 (7 Monate vor) • Business Wire

TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
Mittwoch 26 Juni 2024 (7 Monate vor) • Business Wire

Weitere TriSalus Life Sciences Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen